Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association

Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association

Aim of publication. To present the latest data on adequate diagnostic methods, treatment approaches and features of rational pharmacotherapy of gastroesophageal reflux disease (GERD) based on the principles of evidencebased medicine to general practitioners. Summary. The prevalence of GERD occupies...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, I. V. Mayev, I. . A.s. Trukhmanov, Ye. K. Baranskaya, O. B. Dronova, O. V. Zayratyants, R. G. Sayfutdinov, A. A. Sheptulin, T. L. Lapina, S. S. Pirogov, Yu. A. Kucheryavy, O. A. Storonova, D. N. Andreyev
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	гастроэзофагеальная рефлюксная болезнь гастроэзофагеальный рефлюкс рефлюкс-эзофагит неэрозивная рефлюксная болезнь «кислотный карман» ингибитор протонной помпы альгинат ангтацид прокинетический препарат
Online Access:	https://www.gastro-j.ru/jour/article/view/171
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
by: Yu. V. Yevsyutina
Published: (2018-08-01)

Pleiotropic effects of rabeprazole at acid-related diseases
by: A. V. Zaborovsky, et al.
Published: (2018-08-01)

Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
by: V. I. Simanenkov, et al.
Published: (2018-08-01)

Esophageal adenocarcinoma: risk factors and modern screening strategy
by: I. V. Mayev, et al.
Published: (2018-08-01)

Modern options of prokinetics in gastroesophageal reflux disease treatment
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Clinical impact of 24-hour pH-metry in esophageal and stomach diseases diagnostics and pharmacological drugs efficacy testing
by: A. S. Trukhmanov, et al.
Published: (2018-08-01)

Treatment compliance of patients with gastro-intestinal diseases
by: O. P. Alekseyeva, et al.
Published: (2016-08-01)

High-resolution manometry in clinical practice: analysis of esophageal motor function according to Chicago classification
by: O. A. Storonova, et al.
Published: (2018-08-01)

Effect of antisecretory treatment on gastrointestinal microbiota
by: D. Ye. Rumyantseva, et al.
Published: (2018-08-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Clinical round: 27 year old patient with initially diagnosed Crohn's disease and severe protein and energy deficiency
by: V. S. Scherbakha, et al.
Published: (2018-08-01)

Diagnostics and treatment of peptic ulcer: clinical guidelines of the Russian gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Peptic ulcer: does it changed identity?
by: Ye. A. Pyatenko, et al.
Published: (2018-08-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

The effect of maintenance therapy on Crohn’s disease clinical outcomes
by: O. B. Schukina, et al.
Published: (2018-08-01)

Successful endoscopic treatment of diverticular disease complicated by paracolic abscess
by: A. I. Khripun, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
by: I. G. Bakulin, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

Chronic inflammatory bowel diseases: the course and treatment methods in Russian Federation (Results of multicenter population-based one-stage observational study)
by: L. . Khalif, et al.
Published: (2018-08-01)

Treatment compliance of liver cirrhosis patients
by: Ye. R. Olevskaya, et al.
Published: (2018-08-01)

Features of pathogenesis, diagnostics and treatment of gallstone disease at pregnancy
by: Yu. B. Uspenskaya, et al.
Published: (2018-08-01)

Microbiome in development of esophageal diseases
by: Yu. V. Yevsyutina, et al.
Published: (2016-08-01)

Surgical treatment of the fistulizing Crohn's disease with anterior abdominal wall reconstruction (Clinical case)
by: Yu. Ye. Kitsenko, et al.
Published: (2018-08-01)

Noninvasive markers of inflammatory bowel disease activity
by: A. V. Nikitin, et al.
Published: (2018-08-01)

Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Postcholecystectomy syndrome: the modern approach: resolution of Advisory council
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Population features of prevalence and clinical-diagnostic role of NOD2 gene polymorphisms associated with Crohn’s disease
by: D. A. Kuznetsova, et al.
Published: (2018-08-01)

Improvement of Helicobacter pylori eradication efficacy at stomach and duodenum peptic ulcers
by: Natalya O. Schanova, et al.
Published: (2016-08-01)

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
by: P. V. Tsarkov, et al.
Published: (2018-08-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
by: T. P. Rozina, et al.
Published: (2018-08-01)

Hexapeptide dalargin in clinical gastroenterology: 30 years' of clinical application of the drug
by: S. A. Bulgakov
Published: (2016-08-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
by: Е. V. Garanina
Published: (2021-12-01)